Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.37%43.95B | 1.77%45.02B | -23.72%9.25B | 3.34%12.41B | 16.34%12.34B | 16.09%11.02B | 26.36%44.24B | 23.24%12.13B | 27.65%12.01B | 39.95%10.61B |
| Cost of revenue | -2.92%38.56B | 4.12%39.72B | -19.98%8.28B | 5.02%10.93B | 14.89%10.59B | 21.31%9.92B | 28.92%38.15B | 23.40%10.35B | 31.24%10.41B | 41.24%9.21B |
| Gross profit | 1.79%5.4B | -12.94%5.3B | -45.46%974M | -7.52%1.48B | 25.72%1.76B | -16.40%1.1B | 12.36%6.09B | 22.33%1.79B | 8.20%1.6B | 32.07%1.4B |
| Operating expense | 0.88%2.4B | 4.16%2.38B | -0.84%588M | 7.29%633M | 5.87%595M | 4.45%563M | 3.25%2.28B | -0.84%593M | 1.03%590M | 12.85%562M |
| Operating profit | 2.53%3B | -23.21%2.92B | -67.64%386M | -16.20%843M | 39.09%1.16B | -30.96%533M | 18.65%3.81B | 38.40%1.19B | 12.91%1.01B | 49.19%834M |
| Net non-operating interest income (expenses) | 53.52%218M | 118.46%142M | 100.00%44M | 85.00%37M | 161.54%34M | 170.00%27M | 80.56%65M | 144.44%22M | 122.22%20M | 30.00%13M |
| Non-operating interest income | 53.42%247M | 109.09%161M | 96.00%49M | 86.96%43M | 137.50%38M | 138.46%31M | 60.42%77M | 108.33%25M | 91.67%23M | 23.08%16M |
| Non-operating interest expense | 52.63%29M | 58.33%19M | 66.67%5M | 100.00%6M | 33.33%4M | 33.33%4M | 0.00%12M | 0.00%3M | 0.00%3M | 0.00%3M |
| Net investment income | -1,350.00%-25M | 104.55%2M | -106.25%-1M | 102.04%1M | 0.00%-10M | 1,300.00%12M | -438.46%-44M | 700.00%16M | -1,733.33%-49M | -242.86%-10M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 16M | 0 | 0 | 0 | 0 | 0 | ||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -20.37%86M | 1,100.00%108M | 800.00%91M | -12.50%7M | -620.00%-26M | 300.00%36M | -55.00%9M | -13M | -20.00%8M | -28.57%5M |
| Less:Other special charges | 20.37%-86M | -1,100.00%-108M | -800.00%-91M | 12.50%-7M | 620.00%26M | -300.00%-36M | 55.00%-9M | --13M | 20.00%-8M | 28.57%-5M |
| Other non-operating income (expenses) | -47.62%55M | 228.13%105M | 514.29%43M | 8.33%13M | 300.00%2M | 235.71%47M | 0.00%32M | -46.15%7M | 140.00%12M | -112.50%-1M |
| Income before tax | 1.03%3.33B | -14.77%3.3B | -53.93%563M | -9.71%902M | 39.60%1.17B | -18.41%656M | 16.87%3.87B | 38.08%1.22B | 8.71%999M | 43.03%841M |
| Income tax | 16.63%982M | -13.91%842M | -40.94%163M | -13.03%207M | 19.61%305M | -20.10%167M | 3.16%978M | 23.21%276M | -11.19%238M | 55.49%255M |
| Net income | -4.32%2.35B | -15.07%2.45B | -57.82%399M | -8.42%696M | 48.04%869M | -17.85%488M | 22.38%2.89B | 43.33%946M | 16.56%760M | 38.44%587M |
| Net income continuous operations | -4.32%2.35B | -15.06%2.45B | -57.72%400M | -8.67%695M | 48.29%869M | -17.82%489M | 22.37%2.89B | 43.12%946M | 16.90%761M | 38.21%586M |
| Noncontrolling interests | 4.50%348M | 30.59%333M | 21.05%92M | 11.27%79M | 45.45%96M | 57.14%66M | 77.08%255M | 76.74%76M | 54.35%71M | 186.96%66M |
| Net income attributable to the company | -5.71%2B | -19.49%2.12B | -64.64%308M | -10.60%616M | 48.65%773M | -23.55%422M | 18.83%2.63B | 41.17%871M | 13.51%689M | 29.68%520M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -5.71%2B | -19.49%2.12B | -64.64%308M | -10.60%616M | 48.65%773M | -23.55%422M | 18.83%2.63B | 41.17%871M | 13.51%689M | 29.68%520M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -5.57%679.15 | -18.26%719.21 | -64.47%104.49 | -9.51%209.01 | 52.36%262.4 | -21.53%143.31 | 20.08%879.91 | 44.02%294.08 | 15.20%230.97 | 29.84%172.22 |
| Diluted earnings per share | -5.57%679.15 | -18.26%719.21 | -64.47%104.49 | -9.51%208.997 | 52.49%262.2601 | -21.53%143.31 | 20.08%879.91 | 44.11%294.08 | 15.20%230.97 | 29.68%171.9862 |
| Dividend per share | 12.71%133 | 31.11%118 | 0.00%60 | 0 | 93.33%58 | 0 | 21.62%90 | 36.36%60 | 0 | 0.00%30 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |